ZA848541B - A kit or device and method for administering gangliosides and derivatives thereof by inhalation and pharmaceutical compositions suitable therefor - Google Patents

A kit or device and method for administering gangliosides and derivatives thereof by inhalation and pharmaceutical compositions suitable therefor

Info

Publication number
ZA848541B
ZA848541B ZA848541A ZA848541A ZA848541B ZA 848541 B ZA848541 B ZA 848541B ZA 848541 A ZA848541 A ZA 848541A ZA 848541 A ZA848541 A ZA 848541A ZA 848541 B ZA848541 B ZA 848541B
Authority
ZA
South Africa
Prior art keywords
kit
inhalation
derivatives
pharmaceutical compositions
compositions suitable
Prior art date
Application number
ZA848541A
Other languages
English (en)
Inventor
Francesco Della Valle
Aurelio Romeo
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of ZA848541B publication Critical patent/ZA848541B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA848541A 1983-11-08 1984-11-01 A kit or device and method for administering gangliosides and derivatives thereof by inhalation and pharmaceutical compositions suitable therefor ZA848541B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8349288A IT1212896B (it) 1983-11-08 1983-11-08 Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative

Publications (1)

Publication Number Publication Date
ZA848541B true ZA848541B (en) 1985-06-26

Family

ID=11270228

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA848541A ZA848541B (en) 1983-11-08 1984-11-01 A kit or device and method for administering gangliosides and derivatives thereof by inhalation and pharmaceutical compositions suitable therefor

Country Status (22)

Country Link
US (1) US4639437A (xx)
EP (1) EP0145209B1 (xx)
JP (1) JPS60132920A (xx)
KR (1) KR850003503A (xx)
AT (1) ATE47035T1 (xx)
AU (1) AU569920B2 (xx)
BE (1) BE900994A (xx)
CH (1) CH662278A5 (xx)
DE (1) DE3480053D1 (xx)
DK (1) DK160129C (xx)
ES (1) ES8608532A1 (xx)
FR (1) FR2554346B1 (xx)
GR (1) GR80853B (xx)
IL (1) IL73292A (xx)
IN (1) IN163563B (xx)
IT (1) IT1212896B (xx)
LU (1) LU85633A1 (xx)
MX (1) MX163574B (xx)
NO (1) NO844443L (xx)
NZ (1) NZ209974A (xx)
PT (1) PT79466B (xx)
ZA (1) ZA848541B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
JPS6368526A (ja) * 1986-09-11 1988-03-28 Mect Corp シアリルグリセライドからなる神経障害疾患治療剤
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
US4937232A (en) * 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US6407061B1 (en) 1989-12-05 2002-06-18 Chiron Corporation Method for administering insulin-like growth factor to the brain
US5624898A (en) 1989-12-05 1997-04-29 Ramsey Foundation Method for administering neurologic agents to the brain
AU6909091A (en) * 1989-12-05 1991-06-26 Ramsey Foundation Neurologic agents for nasal administration to the brain
IT1249034B (it) * 1990-06-29 1995-02-11 Fidia Spa Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi
WO1992017189A1 (en) * 1991-03-29 1992-10-15 The Regents Of The University Of California Gangliosides with immunosuppressive activity
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5567684A (en) * 1994-09-14 1996-10-22 The Regents Of The University Of California Synthetic ganglioside derivatives
US7273618B2 (en) * 1998-12-09 2007-09-25 Chiron Corporation Method for administering agents to the central nervous system
AU2002326805B2 (en) 2001-08-29 2009-01-22 Seneb Biosciences, Inc. Novel synthetic ganglioside derivatives and compositions thereof
NZ542148A (en) 2003-03-06 2008-05-30 Neose Technologies Inc Methods and compositions for the enzymatic synthesis of gangliosides
CU23317A1 (es) 2005-07-22 2008-10-22 Ct De Investigacia N Y Desarro Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central
US20120035120A1 (en) 2009-03-25 2012-02-09 Seneb Biosciences, Inc. Glycolipids as treatment for disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL262354A (xx) * 1960-03-17
US3282781A (en) * 1960-11-25 1966-11-01 Merck & Co Inc Inhalant compositions
US4094968A (en) * 1972-09-06 1978-06-13 Burroughs Wellcome Co. Treatment for allergy and method of composition thereof
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
US4476119A (en) * 1981-08-04 1984-10-09 Fidia S.P.A. Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions

Also Published As

Publication number Publication date
IL73292A0 (en) 1985-01-31
DK160129C (da) 1991-07-01
ES8608532A1 (es) 1986-07-16
DK160129B (da) 1991-02-04
EP0145209B1 (en) 1989-10-11
DK505584D0 (da) 1984-10-23
ATE47035T1 (de) 1989-10-15
JPS60132920A (ja) 1985-07-16
EP0145209A2 (en) 1985-06-19
PT79466A (en) 1984-12-01
NZ209974A (en) 1987-02-20
AU569920B2 (en) 1988-02-25
GR80853B (en) 1985-02-26
BE900994A (nl) 1985-05-07
CH662278A5 (fr) 1987-09-30
ES537300A0 (es) 1986-07-16
IL73292A (en) 1988-07-31
DE3480053D1 (en) 1989-11-16
US4639437A (en) 1987-01-27
IT8349288A0 (it) 1983-11-08
EP0145209A3 (en) 1986-11-26
NO844443L (no) 1985-05-09
AU3518984A (en) 1985-05-16
JPH0211570B2 (xx) 1990-03-14
LU85633A1 (fr) 1985-06-04
FR2554346B1 (fr) 1987-11-20
PT79466B (en) 1986-12-12
KR850003503A (ko) 1985-06-20
MX163574B (es) 1992-06-02
IT1212896B (it) 1989-11-30
DK505584A (da) 1985-05-09
IN163563B (xx) 1988-10-08
FR2554346A1 (fr) 1985-05-10

Similar Documents

Publication Publication Date Title
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
UA41906C2 (uk) Спосіб лікування неврологічних порушень, викликаних травмами
IL133585A0 (en) Soluble prodrugs of paclitaxel
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
JPS6485984A (en) Methylenephosphonoalkylphosphinates, medicinal composition and therapy for abnormal calcium and phosphate metabolism
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
IL68456A0 (en) Pharmaceutical compositions comprising perfluorohydrocarbons as vehicles
ES8306483A1 (es) Procedimiento de preparacion de las dibezooxepinas sustituidas y de sus sales de adicion con un acido mineral u organico
SE8500996D0 (sv) Method of treatment
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
ZA826453B (en) Tricyclic thiazolyloxamic acids and their derivatives,their preparation,and therapeutic agents containing these compounds
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
JPS5753475A (en) Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same
ATE275953T1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
HUT73500A (en) Use of benzydamine for producing pharmaceutical compositions for treatment of pathological conditions caused by tnf
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater
ZA896464B (en) Use of 2-azabicyclo(2.2.2)octane-3-carboxylic acid derivatives for the production of medicinal products intended for the treatment of diseases resulting from impairment of the vascular wall as well as for disorders of the microcirculation
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
UA10093A (uk) Спосіб лікування захворювань товстої кишки
ATE94758T1 (de) Verwendung von gangliosiden zur behandlung der dysfunktion des autonomen nervensystems bei der chagas-krankheit.